Grant Details
Grant Number: |
5R01CA160744-04 Interpret this number |
Primary Investigator: |
Kim, Jane |
Organization: |
Harvard School Of Public Health |
Project Title: |
Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases |
Fiscal Year: |
2015 |
Abstract
DESCRIPTION (provided by applicant): Each year, more than 25,000 cases of invasive cancer attributable to human papillomavirus (HPV) infection occur in the United States; nearly 50% are cervical cancer, while the rest involve the oral cavity/oropharynx, anus, vulva, penis, and vagina. Collectively, these account for substantial morbidity and mortality, contribute to health disparities, and are associated with high economic costs. Advancements in HPV-related cancer epidemiology, coupled with new (e.g., HPV-16,-18 vaccines, HPV DNA testing) and emerging (e.g., biomarkers, therapeutic vaccines) technologies provide a remarkable opportunity to improve cancer prevention efforts. However, critical challenges remain with respect to clinical decision-making and prevention policy, pertaining to knowledge gaps and heterogeneities in the natural history of different cancers, uncertainties in HPV type distribution following HPV-16,-18 vaccination, and the real-world clinical effectiveness of emerging technologies. We propose to employ a decision-analytic approach, developing a flexible modeling framework that will allow us to synthesize the best available data; evaluate the health and economic consequences of alternative strategies; explore the uncertainty around their outcomes; explicitly quantify the tradeoffs associated with different approaches; and inform timely clinical and policy questions. By achieving our aims, we expect to have an impact on (1) the analytic methods of decision science; (2) the equitable distribution and rationale use of new technology; (3) the effectiveness of strategies for cancer prevention through clinical guidelines and national policies; (4) HPV-related cancer outcomes, including reduced incidence, enhanced quality of life, improved survival, and reduced disparities; and (5) the financial and economic profile of delivering cancer-related health services.
Publications
Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.
Authors: Burger E.A.
, Dyer M.A.
, Sy S.
, Palefsky J.M.
, de Pokomandy A.
, Coutlee F.
, Silverberg M.J.
, Kim J.J.
.
Source: Journal of acquired immune deficiency syndromes (1999), 2018-09-01; 79(1), p. 10-19.
PMID: 29757775
Related Citations
Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
Authors: Pedersen K.
, Burger E.A.
, Nygård M.
, Kristiansen I.S.
, Kim J.J.
.
Source: European journal of cancer (Oxford, England : 1990), 2018 03; 91, p. 68-75.
EPub date: 2018-01-12.
PMID: 29335156
Related Citations
Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer.
Authors: Burger E.A.
, Kim J.J.
, Sy S.
, Castle P.E.
.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017-09-15; 65(6), p. 893-899.
PMID: 28531261
Related Citations
Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway.
Authors: Burger E.A.
, Pedersen K.
, Sy S.
, Kristiansen I.S.
, Kim J.J.
.
Source: British journal of cancer, 2017-09-05; 117(6), p. 783-790.
EPub date: 2017-08-03.
PMID: 28772279
Related Citations
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Authors: Kim J.J.
, Burger E.A.
, Sy S.
, Campos N.G.
.
Source: Journal of the National Cancer Institute, 2017 02; 109(2), .
EPub date: 2016-10-18.
PMID: 27754955
Related Citations
The Cost-Effectiveness of Cervical Self-Sampling to Improve Routine Cervical Cancer Screening: The Importance of Respondent Screening History and Compliance.
Authors: Burger E.A.
, Sy S.
, Nygård M.
, Kim J.J.
.
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2017 01; 26(1), p. 95-103.
EPub date: 2016-09-13.
PMID: 27624639
Related Citations
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.
Authors: Brisson M.
, Bénard É.
, Drolet M.
, Bogaards J.A.
, Baussano I.
, Vänskä S.
, Jit M.
, Boily M.C.
, Smith M.A.
, Berkhof J.
, et al.
.
Source: The Lancet. Public health, 2016 11; 1(1), p. e8-e17.
EPub date: 2016-09-27.
PMID: 29253379
Related Citations
Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing.
Authors: Pedersen K.
, Burger E.A.
, Sy S.
, Kristiansen I.S.
, Kim J.J.
.
Source: Gynecologic oncology, 2016 Nov; 143(2), p. 326-333.
EPub date: 2016-08-17.
PMID: 27542966
Related Citations
Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines.
Authors: Burger E.A.
, Lee K.
, Saraiya M.
, Thompson T.D.
, Chesson H.W.
, Markowitz L.E.
, Kim J.J.
.
Source: Cancer, 2016-07-01; 122(13), p. 2057-66.
EPub date: 2016-04-28.
PMID: 27124396
Related Citations
Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Authors: Campos N.G.
, Castle P.E.
, Wright T.C.
, Kim J.J.
.
Source: International journal of cancer, 2015-11-01; 137(9), p. 2208-19.
EPub date: 2015-05-21.
PMID: 25943074
Related Citations
Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.
Authors: Burger E.A.
, Sy S.
, Nygård M.
, Kristiansen I.S.
, Kim J.J.
.
Source: The Journal of infectious diseases, 2015-01-15; 211(2), p. 206-15.
EPub date: 2014-07-23.
PMID: 25057044
Related Citations
The value of improving failures within a cervical cancer screening program: an example from Norway.
Authors: Burger E.A.
, Kim J.J.
.
Source: International journal of cancer, 2014-10-15; 135(8), p. 1931-9.
EPub date: 2014-03-20.
PMID: 24615416
Related Citations
Practice-based evidence for primary HPV testing in the United States.
Authors: Kim J.J.
.
Source: Journal of the National Cancer Institute, 2014 Aug; 106(8), .
EPub date: 2014-07-18.
PMID: 25038468
Related Citations
Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.
Authors: Burger E.A.
, Sy S.
, Nygård M.
, Kristiansen I.S.
, Kim J.J.
.
Source: PloS one, 2014; 9(3), p. e89974.
EPub date: 2014-03-20.
PMID: 24651645
Related Citations
Comprehensive control of human papillomavirus infections and related diseases.
Authors: Bosch F.X.
, Broker T.R.
, Forman D.
, Moscicki A.B.
, Gillison M.L.
, Doorbar J.
, Stern P.L.
, Stanley M.
, Arbyn M.
, Poljak M.
, et al.
.
Source: Vaccine, 2013-12-31; 31 Suppl 7, p. H1-31.
PMID: 24332295
Related Citations
Comprehensive control of human papillomavirus infections and related diseases.
Authors: Bosch F.X.
, Broker T.R.
, Forman D.
, Moscicki A.B.
, Gillison M.L.
, Doorbar J.
, Stern P.L.
, Stanley M.
, Arbyn M.
, Poljak M.
, et al.
.
Source: Vaccine, 2013-12-30; 31 Suppl 6, p. G1-31.
PMID: 24331817
Related Citations
Comprehensive control of human papillomavirus infections and related diseases.
Authors: Bosch F.X.
, Broker T.R.
, Forman D.
, Moscicki A.B.
, Gillison M.L.
, Doorbar J.
, Stern P.L.
, Stanley M.
, Arbyn M.
, Poljak M.
, et al.
.
Source: Vaccine, 2013-12-29; 31 Suppl 5, p. F1-31.
PMID: 24331745
Related Citations
Comprehensive control of human papillomavirus infections and related diseases.
Authors: Bosch F.X.
, Broker T.R.
, Forman D.
, Moscicki A.B.
, Gillison M.L.
, Doorbar J.
, Stern P.L.
, Stanley M.
, Arbyn M.
, Poljak M.
, et al.
.
Source: Vaccine, 2013-11-22; 31 Suppl 8, p. I1-31.
PMID: 24229716
Related Citations
Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients.
Authors: Assoumou S.A.
, Mayer K.H.
, Panther L.
, Linas B.P.
, Kim J.
.
Source: Sexually transmitted diseases, 2013 Apr; 40(4), p. 298-303.
PMID: 23486494
Related Citations
Modeling preventative strategies against human papillomavirus-related disease in developed countries.
Authors: Canfell K.
, Chesson H.
, Kulasingam S.L.
, Berkhof J.
, Diaz M.
, Kim J.J.
.
Source: Vaccine, 2012-11-20; 30 Suppl 5, p. F157-67.
PMID: 23199959
Related Citations